✦ LIBER ✦

Safety aspects of the LHRH antagonist cetrorelix (cetrotide®)

✍ Scribed by H. Riethmüller-Winzen; A. Prothmann; Th. Reissmann; M. Peukert; J. Engel

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Plasma and follicular fluid concentratio

✍ M. Ludwig; C. Albano; F. Olivennes; R. E. Felberbaum; J. Smitz; O. Ortmann; P. R 📂 Article 📅 2002 🏛 Springer 🌐 English ⚖ 46 KB

Health Condition of 227 Children Born Af

✍ M Ludwig; H Riethmüller-Winzen; R.E Felberbaum; F Olivennes; P Devroey; K Diedri 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 29 KB

Significant reduction of the incidence o

✍ M. Ludwig; R. E. Felberbaum; P. Devroey; C. Albano; H. Riethmüller-Winzen; A. Sc 📂 Article 📅 2000 🏛 Springer 🌐 English ⚖ 39 KB

Effects of the LHRH antagonist Cetroreli

✍ Gyula Telegdy; Masaru Tanaka; Andrew V. Schally 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 638 KB

Effects of the LHRH antagonist Cetroreli

✍ G. Telegdy; A. Adamik; M. Tanaka; A.V. Schally 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 625 KB

No significant leukocytosis under contro

✍ M Ludwig; D Strik; R Felberbaum; S Al-Hasani; K Diedrich 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 47 KB